Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing–remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS
Meng, Xiangyi, Chin, Peter S., Hashmonay, Ron, Zahur Islam, M., Cutter, GaryVolume:
41
Language:
english
Journal:
Contemporary Clinical Trials
DOI:
10.1016/j.cct.2014.12.011
Date:
March, 2015
File:
PDF, 659 KB
english, 2015